1252 related articles for article (PubMed ID: 15504576)
1. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
2. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
Parra MC; Lees C; Mann GE; Pearson JD; Nicolaides KH
Am J Obstet Gynecol; 2001 Feb; 184(3):497-502. PubMed ID: 11228509
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary hypertension: the role of nitric oxide in adults].
Neidecker J
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
[TBL] [Abstract][Full Text] [Related]
6. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium.
Escudero C; Sobrevia L
Placenta; 2008 Jun; 29(6):469-83. PubMed ID: 18359514
[TBL] [Abstract][Full Text] [Related]
7. Expression of phosphodiesterase 5 in maternal and fetal sheep.
Coppage KH; Sun X; Baker RS; Clark KE
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1005-10. PubMed ID: 16157102
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
Villar J; Carroli G; Wojdyla D; Abalos E; Giordano D; Ba'aqeel H; Farnot U; Bergsjø P; Bakketeig L; Lumbiganon P; Campodónico L; Al-Mazrou Y; Lindheimer M; Kramer M;
Am J Obstet Gynecol; 2006 Apr; 194(4):921-31. PubMed ID: 16580277
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide pathway in placental dysfunction following fetal bypass.
Lam C; Baker RS; McNamara J; Ferguson R; Lombardi J; Clark K; Eghtesady P
Ann Thorac Surg; 2007 Sep; 84(3):917-24; discussion 924-5. PubMed ID: 17720400
[TBL] [Abstract][Full Text] [Related]
10. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries.
Wareing M; Myers JE; O'hara M; Kenny LC; Warren AY; Taggart MJ; Skillern L; Machin I; Baker PN
Am J Obstet Gynecol; 2004 May; 190(5):1283-90. PubMed ID: 15167831
[TBL] [Abstract][Full Text] [Related]
11. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia.
Aris A; Benali S; Ouellet A; Moutquin JM; Leblanc S
Placenta; 2009 Apr; 30(4):342-7. PubMed ID: 19223072
[TBL] [Abstract][Full Text] [Related]
12. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.
Kaufmann P; Black S; Huppertz B
Biol Reprod; 2003 Jul; 69(1):1-7. PubMed ID: 12620937
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
14. Pre-eclampsia.
Mathai M
Ceylon Med J; 1996 Mar; 41(1):7-9. PubMed ID: 8754607
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
17. [Observations on pe-eclampsia-eclampsia and the advances in the evolution of some laboratory tests].
Noguera Sánchez MF; Ayala Barahona T; Arredondo Soberón F; Morgan MA
Ginecol Obstet Mex; 1997 Jul; 65():300-4. PubMed ID: 9312519
[TBL] [Abstract][Full Text] [Related]
18. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
Werkström V; Svensson A; Andersson KE; Hedlund P
BJU Int; 2006 Aug; 98(2):414-23. PubMed ID: 16626307
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension in pregnancy].
Delmis J
Lijec Vjesn; 2006; 128(11-12):357-68. PubMed ID: 17212198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
